We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App




Point-of-Care Device Accurately Rapidly Diagnoses Sickle Cell Disease

By LabMedica International staff writers
Posted on 25 Nov 2021
Hemoglobinopathies are the most common autosomal hereditary disorders. More...
Approximately 7% of the global population carries hemoglobin gene mutation including structural hemoglobin variants like sickle hemoglobin or thalassemia.

Sickle cell disease is a major public health problem in India. Lack of rapid and reliable diagnostic methods result in many avoidable deaths in affected population. Current diagnostic tools are laboratory based, expensive and need trained manpower. Early diagnosis is crucial to initiating life-saving therapies and knowledge of sickle cell carrier status is critical to prevention and parental planning for at-risk populations.

Medical Scientists at the ICMR-National Institute of Research in Tribal Health (Jabalpur, India) screened a total of 1,050 patients by sickle cell solubility, hemoglobin (cellulose acetate) electrophoresis, high-performance liquid chromatography (HPLC) and the Gazelle point-of-care device. Sickle positive samples were also confirmed by HPLC using Beta-thalassemia (betathal) short program (VARIANT II, Bio-Rad Laboratories, Inc., Hercules, CA, USA). HPLC and standard cellulose acetate electrophoresis were considered to be the reference standard for comparisons.

Gazelle (Hemex Health, Portland, OR, USA) is a single-use cartridge-based test that enables rapid, affordable, quantitative, accurate diagnosis for both sickle cell anemia (SCA) and carrier status at the point of care. It is a cellulose acetate-based microchip electrophoresis system within a portable instrument, utilizing the principle of standard electrophoresis method with inbuilt analysis software, electronic data storage, and wireless data transmission capabilities. The test provides actionable quantitative hemoglobin information from a finger stick blood sample during the patient visit in less than 10 minutes.

The investigators reported that of the total 1,027 test results obtained, 960 tests were “Valid” (93.5%) and included in the analysis. Gazelle identified all patients with disease (HbSS and Thalassemia Major) with 100% accuracy. Gazelle demonstrated 100% sensitivity when comparing sickle cell disease (SCD) versus sickle cell trait and SCD versus normal. Specificity was 98.9% and 99.5% when comparing SCD versus trait and trait versus normal, respectively. Specificity was 99.8% when comparing SCD versus normal and sensitivity was 99.3% when comparing trait versus normal. Overall, Gazelle yielded a high accuracy (99.0%) compared to reference standard tests (hemoglobin electrophoresis and HPLC).

The authors concluded that Gazelle is a low-cost, rapid diagnostic test with high accuracy for detecting SCD both quantitatively and qualitatively. Gazelle can be a potential screening tool for the rapid diagnosis in resource limited settings and developing countries with high burden of hemoglobin disorders. The study was published on October 13, 2021 in the journal Frontiers in Medicine.

Related Links:
ICMR-National Institute of Research in Tribal Health
Bio-Rad Laboratories
Hemex Health



Gold Member
Troponin T QC
Troponin T Quality Control
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
New
Drug Test Kit
DrugCheck 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
Image: Pancreatic cancer diagnosis (Photo courtesy of World Journal of Gastroenterology)

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.